“The gadolinium chelates (the GBCAs) are critical to disease diagnosis by MR, indeed to clinical medicine worldwide, and have proven to be overall a very safe class of contrast media.” This review focuses on the current knowledge regarding accumulation of gadolinium in the brain (dentate nucleus and other structures) and body, with clinical recommendations based on that and other safety data, including the recent European Agency recommendation.
This abstract and the presentation materials are available to members only; a login is required.